Search Results - "Jha, T. K."

Refine Results
  1. 1

    Injectable Paromomycin for Visceral Leishmaniasis in India by Sundar, Shyam, Jha, T.K, Thakur, Chandreshwar P, Sinha, Prabhat K, Bhattacharya, Sujit K

    Published in The New England journal of medicine (21-06-2007)
    “…Visceral leishmaniasis (kala-azar) disproportionately affects the rural poor, with approximately 500,000 cases worldwide. Treatment options are limited,…”
    Get full text
    Journal Article
  2. 2

    Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study by Sundar, S., Jha, T. K., Thakur, C. P., Mishra, M., Singh, V. P., Buffels, R.

    Published in Clinical infectious diseases (15-09-2003)
    “…Widespread antimony resistance renders conventional amphotericin B the only option for the treatment of visceral leishmaniasis (VL) in North Bihar, India…”
    Get full text
    Journal Article
  3. 3

    Efficacy and Tolerability of Miltefosine for Childhood Visceral Leishmaniasis in India by Bhattacharya, Sujit K., Jha, T. K., Sundar, Shyam, Thakur, C. P., Engel, Juergen, Sindermann, Herbert, Junge, Klaus, Karbwang, Juntra, Bryceson, Anthony D. M., Berman, Jonathan D.

    Published in Clinical infectious diseases (15-01-2004)
    “…Miltefosine has previously been shown to cure 97% of cases of visceral leishmaniasis (VL) in Indian adults. Because approximately one-half of cases of VL occur…”
    Get full text
    Journal Article
  4. 4

    Oral miltefosine for Indian post‐kala‐azar dermal leishmaniasis: a randomised trial by Sundar, Shyam, Sinha, Prabat, Jha, T. K., Chakravarty, Jaya, Rai, Madhukar, Kumar, Nawin, Pandey, Krishna, Narain, M. K., Verma, N., Das, V. N. R., Das, P., Berman, Jonathan, Arana, Byron

    Published in Tropical medicine & international health (01-01-2013)
    “…Objective Standard treatment of Indian post‐kala‐azar dermal leishmaniasis (PKDL) is unsatisfactory because to achieve therapeutic effectiveness, heroic…”
    Get full text
    Journal Article
  5. 5

    Oral Miltefosine for Indian Visceral Leishmaniasis by Sundar, Shyam, Jha, T.K, Thakur, C.P, Engel, Juergen, Sindermann, Herbert, Fischer, Christina, Junge, Klaus, Bryceson, Anthony, Berman, Jonathan

    Published in The New England journal of medicine (28-11-2002)
    “…Miltefosine has been shown to have activity against Indian visceral leishmaniasis, and this agent can be taken orally. This randomized trial in India compared…”
    Get full text
    Journal Article
  6. 6

    Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis by Jha, T.K, Sundar, Shyam, Thakur, C.P, Bachmann, Peter, Karbwang, Juntra, Fischer, Christina, Voss, Andreas, Berman, Jonathan

    Published in The New England journal of medicine (09-12-1999)
    “…Visceral leishmaniasis (kala-azar) is caused by infection of the spleen, liver, bone marrow, and reticuloendothelial system by leishmania that are acquired…”
    Get full text
    Journal Article
  7. 7

    Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis by SUNDAR, SHYAM, JHA, T K, SINDERMANN, HERBERT, JUNGE, KLAUS, BACHMANN, PETER, BERMAN, JONATHAN

    Published in The Pediatric infectious disease journal (01-05-2003)
    “…BACKGROUND.Miltefosine is the first oral drug with demonstrable success in treating visceral leishmaniasis in adults. Because approximately one-half of the…”
    Get full text
    Journal Article
  8. 8

    An Equation of State for Magnetized Neutron Star Matter and Tidal Deformation in Neutron Star Mergers by Patra, N. K., Malik, Tuhin, Sen, Debashree, Jha, T. K., Mishra, Hiranmaya

    Published in The Astrophysical journal (01-09-2020)
    “…We derive an equation of state (EOS) for magnetized charge-neutral nuclear matter relevant for a neutron star (NS). The calculations are performed within an…”
    Get full text
    Journal Article
  9. 9

    Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study by Sundar, S, Jha, T K, Thakur, C P, Mishra, M, Singh, V R, Buffels, R

    “…In this randomized, double-blind, dose-ranging, multicenter trial, 84 patients with visceral leishmaniasis refractory to antimony therapy were administered…”
    Get more information
    Journal Article
  10. 10

    Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India by Sinha, Prabhat K., Jha, T. K., Thakur, Chandreshwar P., Nath, Devendra, Mukherjee, Supriyo, Aditya, Amrendra Kumar, Sundar, Shyam

    Published in Journal of Tropical Medicine (01-01-2011)
    “…Background. A phase 3 study demonstrated the safety and efficacy of paromomycin (paromomycin IM injection) for treatment of VL in an inpatient setting…”
    Get full text
    Journal Article
  11. 11

    Hyperon bulk viscosity and r -modes of neutron stars by Jyothilakshmi, O P, Krishnan, P E Sravan, Thakur, Prashant, Sreekanth, V, Jha, T K

    “…ABSTRACT We propose and apply a new parametrization of the modified chiral effective model to study rotating neutron stars with hyperon cores in the framework…”
    Get full text
    Journal Article
  12. 12

    Drug unresponsiveness & combination therapy for kala-azar by Jha, T K

    “…Pentavalent antimonials (SbV) have been successfully used for treatment of kala-azar since last six decades. Since 1970s its conventional dosages have failed…”
    Get full text
    Journal Article
  13. 13

    Oral miltefosine for the treatment of Indian visceral leishmaniasis by Sundar, Shyam, Jha, T.K., Thakur, C.P., Bhattacharya, S.K., Rai, M.

    “…Large-scale antimony resistance in the treatment of visceral leishmaniasis (VL) in north Bihar, India, has led to the development of miltefosine as an…”
    Get full text
    Journal Article
  14. 14

    Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India by Jha, T K, Giri, Y N, Singh, T K, Jha, S

    “…Thirty-four multidrug-resistant cases of Indian visceral leishmaniasis (kala-azar) were treated with amphotericin B. A complete hemogram, liver and renal…”
    Get more information
    Journal Article
  15. 15

    Massive neutron stars and their implications by JHA, T K, PANDA, KESHAB C

    Published in Pramāṇa (01-05-2014)
    “…Recent observations of high mass pulsar PSRJ1614-2230 has raised serious debate over the possible role of exotics in the dense core of neutron stars. The…”
    Get full text
    Journal Article
  16. 16

    Establishing connection between neutron star properties and nuclear matter parameters through a comprehensive multivariate analysis by Patra, N. K, Saxena, Prafulla, Agrawal, B. K, Jha, T. K

    Published 10-12-2023
    “…Phys. Rev. D (2023) We have attempted to mitigate the challenge of connecting the neutron star (NS) properties with the nuclear matter parameters that describe…”
    Get full text
    Journal Article
  17. 17

    Properties of Neutron Stars with hyperon cores in parameterized hydrostatic conditions by Sen, Debashree, Banerjee, Kinjal, Jha, T. K

    Published 09-12-2018
    “…Int.J.Mod.Phys. E27 (2018) no.11, 1850097 Models of neutron stars (NSs) with hyperon cores are constructed with an effective chiral model in mean-field…”
    Get full text
    Journal Article
  18. 18

    Effects of hadron-quark phase transition on properties of Neutron Stars by Sen, Debashree, Jha, T. K

    Published 19-11-2018
    “…J. Phys. G: Nucl. Part. Phys. 46 (2019) 015202 We investigate the possible scenario of deconfinement of hyperon rich hadronic matter to quark matter at high…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India by Jha, Tara K, Sundar, Shyam, Thakur, Chandreshwar P, Felton, J Mark, Sabin, Antony J, Horton, John

    “…This randomized, open label, multicenter study assessed the dose-response and safety profile for oral sitamaquine in 120 Indian subjects with visceral…”
    Get more information
    Journal Article